Related Experiment Videos
Angiotensin-converting inhibitor enzymes: after the acronyms
1Department of Cardiology, Centre Hospitalier de Verdun, Quebec.
The Canadian Journal of Cardiology
|December 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
Journal of thrombosis and haemostasis : JTH·2013
Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
Alimentary pharmacology & therapeutics·2009
A panel study in congestive heart failure to estimate the short-term effects from personal factors and environmental conditions on oxygen saturation and pulse rate.
Occupational and environmental medicine·2008
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.
Heart (British Cardiac Society)·2006
Treating the right patient at the right time: access to heart failure care.
The Canadian journal of cardiology·2006
ACE-inhibitor use and the long-term risk of renal failure in diabetes.
Kidney international·2006
Taming the Left Subclavian During Frozen Elephant Trunk Procedures: Early results of a novel graft with an integrated fenestration.
The Canadian journal of cardiology·2026
Problematic articles in preclinical literature on microvascular injury after acute myocardial infarction.
The Canadian journal of cardiology·2026
Perioperative Mammillary Body Injury on MRI in Neonates with Severe Congenital Heart Disease.
The Canadian journal of cardiology·2026
The Application of Health Economics in Cardiac Surgery.
The Canadian journal of cardiology·2026
Management of Severe Aortic Stenosis in Patients Receiving Dialysis.
The Canadian journal of cardiology·2026
Impact of Ventricular Stroke Work on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.
The Canadian journal of cardiology·2026
APP Dosage and Extracellular Domain Variants Drive Distinct Defects in Neurogenesis modeled in Down Syndrome iPS cells.
bioRxiv : the preprint server for biology·2026